65,437 trials
Japanese Encephalitis · Measles · Mumps
Primary: Percentage of Participants With Seroconversion to Vaccine Antigens Following Concomitant Administration of Japanese Encephalitis Chimeric Virus Vaccine (JECV) and MMR or…
Amputation · Diabetes · Leg Injuries
Primary: Limb Volume — 0.68; 0.72 liters — p=>0.05
Osteoarthritis
Primary: Exercise Adherence — 57.4; 32.1; 56.2; 35.1 percentage of days adhered — p=<.05
Tetanus · Hepatitis B · Haemophilus Influenzae Type b
Primary: Number of Subjects With Anti-polyribosylribitol Phosphate (Anti-PRP) Above the Cut-off — 204; 188 Participants
Head and Neck Cancer
Primary: Overall Survival (Percentage of Participants Alive) — 64.3; 70.3 percentage of patients — p=0.180
Colorectal Cancer
Primary: Percentage of Participants With Pathological Complete Response (pCR) — 10.00 percentage of participants — p=1.00
Endometrial Adenocarcinoma · Endometrial Adenosquamous Carcinoma · Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
Primary: Histologic Response in Endometrial Adenocarcinomas of the Uterine Corpus That Are Progesterone Receptor Positive Compared With Those That Are Progesterone Receptor…
Smoking
Primary: Smoking Abstinence — 13.0; 13.8; 14.5; 13.3 percentage of abstinent participants
Restless Legs Syndrome
Primary: Change From Baseline (Visit 1) in Clinical Global Impression (CGI) (Item 1 - Severity of Illness) to Visit 2 — -0.8 score on a scale
Chronic Renal Failure
Primary: Renal Function Assessed as Glomerula Filtration Rate (GFR) - Nankivell Method - 9 Months After Renal Transplantation (LOCF) — 15.0; 16.6 mL/min/1.73m^2
Thromboembolism
Primary: Drug Use Problems — 1.25; 0.86; 1.20; 1.17 scores on a scale
Purpura, Thrombocytopenic, Idiopathic
Primary: Summary of Patients Whose Platelet Count Increased by at Least 20,000/mm3 From Baseline to a Total of 30,000/mm3 or More - Week 2 — 8 Participants
HIV
Primary: Seminal Concentrations of Raltegravir. — 0.18; 1.91 mg/l
Rheumatoid Arthritis
Primary: Percentage of Participants Adherent to Original Treatment — 93.75 percentage of participants
Asthma
Primary: Treatment Failure — 29; 28 Percentage of participants